Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests".

Cost and committee reports

Official records Congress.gov attaches to H.J.Res. 145.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Mr. FINSTAD, as printed in the Congressional Record (Vol. 170, No. 85, May 16, 2024, Page H3330):
  Article I, Section 8 of the U.S. Constitution The single subject of this legislation is: Provides for congressional disapproval under Chapter 8 of title 5, United States Code, of the rule submitted by the Food and Drug Administration relating to ``Medical Devices; Laboratory Developed Tests''.
  Source: Congress.gov, Congressional Record May 16, 2024 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  294 characters

  Congress.gov bill record

  H.J.Res. 145, 118th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/118/hjres/145

  Record last updated by Congress.gov

  September 28, 2024

  PORKER copy retrieved

  September 14, 2026

  Stored copy, SHA-256 of the file

  6ccea83c897ddf27741dd28fe18e41e27b25f1b4d624114d3a6184d1bfdc90e2

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of September 28, 2024). Not every bill gets one.

From the Congress.gov bill record for H.J.Res. 145, last updated September 28, 2024. PORKER’s copy was retrieved September 14, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.